Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christine H Soden Insider Profile
4 Followers
Christine H Soden, Director at E Therapeutics, holds 370.00K shares in E Therapeutics (Ticker: GB:ETX), holds 23.43K shares in BTG plc (Ticker: ~BTGGF), holds 19.17K shares in Arecor Therapeutics PLC (Ticker: GB:AREC). Most recently, Christine H Soden Bought ― shares of E Therapeutics on Apr 02, 2019 for an estimated value of 7.00K.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+28.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christine H Soden holds in companies
Most Profitable Insider Trade
Stock:
E Therapeutics
(ETX)
(ETX)
Rating:Informative Buy
Date:Apr 02, 2019 - Apr 02, 2020
Return:+172.50%
The most profitable trade made by Christine H Soden
Christine H Soden's Trading History
E Therapeutics
Apr 02, 2019
―
Informative Buy
7.00K
£33.30K
BTG plc
―
―
―
$235.49K
Elementis
Mar 08, 2022
Director
Informative Buy
10.00K
£45.00K
Arecor Therapeutics PLC
Aug 04, 2022
Director
Informative Buy
20.00K
£17.73K
List of latest transactions for each holding click on a transaction to see Christine H Soden's performance on stock
You May Also Like
Christine H Soden insider profile FAQ
What is the percentage of profitable transactions made by Christine H Soden?
The percentage of profitable transactions made by Christine H Soden is 50%.
What is the average return per transaction made by Christine H Soden?
The average return per transaction made by Christine H Soden is 28.20%.
What stocks does Christine H Soden hold?
Christine H Soden holds: GB:ETX, ~BTGGF, GB:ELM, GB:AREC stocks.
What was Christine H Soden’s latest transaction?
Christine H Soden latest transaction was an Informative Buy of 7.00K.
What was Christine H Soden's most profitable transaction?
Christine H Soden’s most profitable transaction was an Informative Buy of GB:ETX stock on April 2, 2019. The return on the trade was 172.50%.
What is Christine H Soden's role in E Therapeutics?
Christine H Soden's role in E Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.